 |
Pfizer abandons plan to split into twoUS drugmaker Pfizer said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines. Instead, with the two operating as separate bu More… |
Friday 27 December 2024
